[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  CA Shekhar Goel [@Shekhar10884054](/creator/twitter/Shekhar10884054) on x XXX followers Created: 2025-07-24 06:32:09 UTC #INDOCO REMEDIES: Q1 CONS NET LOSS 358M RUPEES VS PROFIT 26.2M (YOY) Q1 REVENUE 4.4B RUPEES VS 4.3B (YOY) Q1 EBITDA RUPEES 103.5MVS 364.5M (YOY) Q1 EBITDA MARGIN XXXX% VS XXXX% XX engagements  [Post Link](https://x.com/Shekhar10884054/status/1948269955838861560)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
CA Shekhar Goel @Shekhar10884054 on x XXX followers
Created: 2025-07-24 06:32:09 UTC
#INDOCO REMEDIES: Q1 CONS NET LOSS 358M RUPEES VS PROFIT 26.2M (YOY)
Q1 REVENUE 4.4B RUPEES VS 4.3B (YOY)
Q1 EBITDA RUPEES 103.5MVS 364.5M (YOY)
Q1 EBITDA MARGIN XXXX% VS XXXX%
XX engagements
/post/tweet::1948269955838861560